Indobufen

Indobufen
Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	B01AC10 (WHO) ;
Identifiers
	IUPAC name 2-(4-(1-Oxoisoindolin-2-yl)phenyl)butanoic acid;
CAS Number	63610-08-2 ;
PubChem CID	107641;
ChemSpider	96823 ;
UNII	6T9949G4LZ;
KEGG	D07141 ;
ChEMBL	ChEMBL1765292 ;
CompTox Dashboard (EPA)	DTXSID7057789 ;
ECHA InfoCard	100.058.496
Chemical and physical data
Formula	C18H17NO3
Molar mass	295.338 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(O)C(c1ccc(cc1)N3C(=O)c2ccccc2C3)CC;
	InChI InChI=1S/C18H17NO3/c1-2-15(18(21)22)12-7-9-14(10-8-12)19-11-13-5-3-4-6-16(13)17(19)20/h3-10,15H,2,11H2,1H3,(H,21,22) ; Key:AYDXAULLCROVIT-UHFFFAOYSA-N ;
	(what is this?) (verify)

Indobufen is a platelet aggregation inhibitor.[1] It acts as a reversible cyclooxygenase inhibitor.[2]

References

The Merck Index (12th ed.). p. 4991.
Eligini S, Violi F, Banfi C, Barbieri SS, Brambilla M, Saliola M, et al. (January 2006). "Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism". Cardiovascular Research. 69 (1): 218–26. doi:10.1016/j.cardiores.2005.07.013. PMID 16154551.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.